BioSpace News Archive

Business

Tilray to Report Second Quarter 2018 Financial Results on August 28, 2018

Tilray Inc. announced it will report results for the second quarter ended June 30, 2018 on Tuesday, August 28, 2018 after market close.

August 7, 2018
·
1 min read
Business

Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2018

Community Healthcare Trust Incorporated (NYSE: CHCT) (the “Company”) today announced results for the three months ended June 30, 2018.

August 7, 2018
·
21 min read
Business

REGENXBIO to Host Conference Call and Webcast on August 8 to Discuss Second Quarter 2018 Financial and Operating Results and Interim Data from Ongoing Clinical Trials

REGENXBIO Inc. announced that its previously announced conference call and webcast on Wednesday, August 8, 2018 at 8:00 a.m. ET to discuss its financial results for the quarter ended June 30, 2018

August 7, 2018
·
1 min read
Business

Computer-Rx Empowers Community Pharmacies with Digital Communications Solutions from Updox

Integrated into the pharmacy management platform, Computer-Rx customers now have access to HIPAA-compliant, two-way texting with patients and digital faxing with prescribers

August 7, 2018
·
4 min read
Policy

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mercury Systems, Rockwell Medical, and Impinj and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. announces that class action lawsuits have been commenced on behalf of stockholders of Mercury Systems, Inc., Rockwell Medical, Inc., and Impinj, Inc.

August 7, 2018
·
2 min read
Business

TSO3 Reports Second Quarter 2018 Results

TSO3 Inc. reported financial results for the second fiscal quarter ended June 30, 2018.

August 7, 2018
·
17 min read
Policy

PCMA Statement on Administration’s Step to Reduce Drug Costs in Medicare Part B

The Pharmaceutical Care Management Association issued the following statement on today’s announcement by the Administration to reduce prescription drug costs in Medicare Part B.

August 7, 2018
·
1 min read
Business

Alternate Health Signs Contract Expected to Significantly Increase Lab Business

Alternate Health Corp. announced that the Company signed a binding contract on August 6, 2018, to provide laboratory services for a large multistate laboratory provider.

August 7, 2018
·
3 min read
Policy

Baron & Budd Secures $110 Million to Settle Texas Whistleblower Lawsuits Against AstraZeneca for Fraudulently Marketing Seroquel, Crestor

Suits Alleged Pharmaceutical Giant Illegally Promoted Seroquel Prescriptions for Children, Misrepresented Safety of Crestor

August 7, 2018
·
4 min read
Business

Medpace Holdings, Inc. Announces Pricing of Secondary Offering of 675,000 shares of Common Stock by Selling Shareholder

Medpace Holdings, Inc. announced the pricing of the previously announced secondary offering of 4,500,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $55.00 per share.

August 7, 2018
·
4 min read